메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Chinese Actress Tiffany Tang Takes the Golden Panda Best Actress in Television: Holding True with Craft, Shining Bright in Changing Times

SHANGHAI, Oct. 13, 2025 -- The Golden Panda Awards, jointly hosted by the China Federation of Literary and Art Circles and the People's Government of Sichuan Province, is a major international film and television cultural award permanently based in Chengdu, Sichuan, held every two years. It comprises three main events — the Golden Panda International Cultural Forum, the Golden Panda Grand Ceremony, and Golden Panda Night — and its mission is to use film and television as a vehicle, with the giant panda as a cultural symbol, to promote cultural exchange, mutual learning among civilizations, an
- 김장윤(JASON KIM) 기자
- 2025-10-13 22:07
DZYNE Expands Dronebuster® Line with New Vehicle Kits at AUSA 2025

Autonomous and Manual Kits deliver mobile, layered counter-drone defense, building on 2,500+ systems fielded in over 50 countries WASHINGTON, Oct. 13, 2025 -- DZYNE Technologies today unveiled its new Dronebuster® Vehicle Kits at the Association of the United States Army (AUSA) Annual Meeting in Washington, D.C. The expansion of the combat-proven Dronebuster® line brings mobile counter-UAS protection to vehicles, convoys, and infrastructure – extending capabilities already trusted by forces in over 50 countries, with more than 2,500 units fielded worldwide. "
- 김갑성 기자
- 2025-10-13 22:00
AMTD's Movie "The Last Dance" Selected for Oscar Academy Awards Race

PARIS, NEW YORK and SINGAPORE, Oct. 13, 2025 -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of the Group under AMTD Digital (NYSE: HKD), jointly announce that AMTD's blockbuster film "The Last Dance" has been selected by the Federation of Motion Film Producers of Hong Kong to represent the Hong Kong Special Administrative Region in the Best International Feature Film category at the 98th Oscar Academy Awards. Beyond this honor, this AMTD film has also received five nomination
- 김장윤(JASON KIM) 기자
- 2025-10-13 21:42
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market

TORONTO, Oct. 13, 2025 -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Holdings (Asia) Limited, has entered into a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. ("Yike"). The agreement grants GV the worldwide rights to apply Yike's breakthrough stem cell technology, which has demonstrated significant potential in advancing treatments for diabetes and with other regenerativ
- 김갑성 기자
- 2025-10-13 21:40
Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

BOSTON, Oct. 13, 2025 -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics laboratory, to its Sequencing Service Provider Program. The Complete Genomics Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms. "We're excited about partnering with Complete Genomics, which we believe will contribut
- 김갑성 기자
- 2025-10-13 21:00
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain

RESORB Study Marks Major Step Toward U.S. Regulatory Approval and Global Commercialization SEOUL, South Korea, Oct. 13, 2025 -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, today announced the enrollment of the first patient in its U.S. pivotal clinical trial evaluating Nexsphere-F™, the company's novel fast resorbable microsphere for musculoskeletal pain embolization. This milestone represents a significant advancement in NEXTBIOMEDICAL's U.S. regulatory pathway, following FDA approval of its Investigational Device
- 김갑성 기자
- 2025-10-13 21:00
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data

CHENGDU, China, Oct. 13, 2025 -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company") is recognized as a biotechnology company pioneering chemically induced allogeneic cell therapy. iRegene's lead product, NouvNeu001, is the 1st iPSC therapy to receive IND approval from both the NMPA and the FDA to treat Parkinson's disease (PD). Recently, NouvNeu001 Phase I clinical data were presented at the International Congress of Parkinson's Disease and Movement Disorders (MDS). Excellent safety and tolerability were observed for up to 15 months post-transplantation, no
- 김갑성 기자
- 2025-10-13 21:00
WiMi Studies Quantum Dilated Convolutional Neural Network Architecture

BEIJING, Oct. 13, 2025 -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that active exploration is underway in the field of Quantum Dilated Convolutional Neural Networks (QDCNN) technology. This technology is expected to break through the limitations of traditional convolutional neural networks in handling complex data and high-dimensional problems, bringing technological leaps to various fields such as image recognition, data analysis, and intelligent pre
- 김장윤(JASON KIM) 기자
- 2025-10-13 21:00
NYSE Content Advisory: Pre-Market Update + LA Times Media Group takes step towards trading debut

NEW YORK, Oct. 13, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE_Market_Update_Oct_13 Kristen Scholer delivers the pre-market update on October 13th The Los Angeles Times Media Group took a step towards trading on the NYSE last week. The group opened a private placement opportunity to be followed by a potential IPO. Dr. Patrick Soon-Shiong, Chairman and CEO of the group, said at the NYSE that he pla
- 황정호 기자
- 2025-10-13 20:58
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between empty, partial, full, and overfull viral vector capsids in less than 10 minutes per sample.2 Decreases sample volumes by 100 times vs. current methods for assessing cells and nucleic acids.3 MILFORD, Mass., Oct. 13, 2025 -- Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS)
- 김갑성 기자
- 2025-10-13 20:36

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-10-15_WED

Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress 00:00

2025-10-14_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 15일 01시 40분